GDNF and neoplasm: This platform enables precise 3D mapping of tumor–nerve interfaces, with implications for identifying neurotrophic signaling pathways (e.g., GDNF/Rearranged during Transfection (RET)) and screening therapeutics targeting neural recruitment in PC models [97].